Literature DB >> 633105

Exchange of 5-hydroxyindoleacetic acid between the spinal cord and lumbar cerebrospinal fluid.

M Bulat, B Zivković.   

Abstract

1. After inhibition of 5-hydroxyindoleacetic acid (5-HIAA) transport by repeated administration of probenecid in cats, this acid accumulates linearly in the lumbosacral cord, lumbar cerebrospinal fluid (c.s.f.) and cisternal fluid during 5 hr of experiment. 2. A simple mathematical analysis of these results shows that (a) the rates of 5-HIAA accumulation in the lumbar c.s.f. and cisternal c.s.f. are faster than in the cord, (b) about 22% of 5-HIAA formed in the cord diffuses into lumbar c.s.f. and (c) by measuring 5-HIAA in the lumbar c.s.f. the concentration and turnover of 5-HIAA and turnover of serotonin in the lumbosacral cord can be calculated as well as the changes of 5-HIAA in the cisternal c.s.f. predicted. 3. These results suggest that it is possible to calculate the level and turnover of endogenous substances in the central nervous system on the basis of their measurement in the c.s.f.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 633105      PMCID: PMC1282540          DOI: 10.1113/jphysiol.1978.sp012185

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  12 in total

1.  CELLULAR LOCALIZATION OF MONOAMINES IN THE SPINAL CORD.

Authors:  A CARLSSON; B FALCK; K FUXE; N A HILLARP
Journal:  Acta Physiol Scand       Date:  1964 Jan-Feb

2.  Inhibition of 5-hydroxyindoleacetic acid transport from the spinal fluid by probenecid.

Authors:  B Zivković; M Bulat
Journal:  J Pharm Pharmacol       Date:  1971-07       Impact factor: 3.765

3.  Clearance of amine metabolites from the cerebrospinal fluid: the brain as a "sink".

Authors:  L I Wolfson; R Katzman; A Escriva
Journal:  Neurology       Date:  1974-08       Impact factor: 9.910

4.  Is cerebrospinal fluid the major avenue for the removal of 5-hydroxyindoleacetic acid from the brain?

Authors:  J L Meek; N H Neff
Journal:  Neuropharmacology       Date:  1973-05       Impact factor: 5.250

5.  5-Hydroxyindoleacetic acid in rat forebrain and cerebrospinal fluid following dorsal and median midbrain raphe lesions.

Authors:  A H Cohen; M B Bowers
Journal:  Brain Res       Date:  1972-04-28       Impact factor: 3.252

6.  Transport of material between brain extracellular fluid, brain cells and blood.

Authors:  J D Fenstermacher; C S Patlak; R G Blasberg
Journal:  Fed Proc       Date:  1974-09

7.  Penetration of 5-hydroxyindoleacetic acid across the blood-cerebrospinal fluid barrier.

Authors:  M Bulat; B Zivković
Journal:  J Pharm Pharmacol       Date:  1973-02       Impact factor: 3.765

8.  Drug-induced changes in the concentration of 5-OR indolyl compounds in cerebrospinal fluid and caudate nucleus.

Authors:  G W ASHCROFT; D F SHARMAN
Journal:  Br J Pharmacol Chemother       Date:  1962-08

9.  Nonhomogeneous distribution of 5-hydroxyindoleacetic acid and homovanillic acid in the lumbar cerebrospinal fluid of man.

Authors:  M Jakupcević; Z Lacković; D Stefoski; M Bulat
Journal:  J Neurol Sci       Date:  1977-03       Impact factor: 3.181

10.  5-Hydroxyindoleacetic acid in the lumbar fluid: a specific indicator of spinal cord injury.

Authors:  M Bulat; Z Lacković; M Jakupcevic; I Damjanov
Journal:  Science       Date:  1974-08-09       Impact factor: 47.728

View more
  2 in total

1.  On the significance of monoamines and their metabolites in the cerebrospinal fluid of the sheep.

Authors:  M Ruckebusch; J F Sutra
Journal:  J Physiol       Date:  1984-03       Impact factor: 5.182

2.  Enigma of cerebrospinal fluid dynamics.

Authors:  Marijan Klarica; Darko Orešković
Journal:  Croat Med J       Date:  2014-08-28       Impact factor: 1.351

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.